Developer of human gene-based therapies. The company has developed a platform to bring new disease-modifying therapies to patients with severe disorders. The company's pipeline includes gene-based therapies for lipoprotein lipase deficiency, or LPLD, Sanfilippo B, Parkinson's Disease and Hemophilia B. read more
Sabah Sallah ā Vice President Clinical Development, Gene Therapy at uniQure
Executive Bio
Sabah Sallah serves as the Vice President Clinical Development, Gene Therapy of uniQure. Sabah started at uniQure in November of 2017. Sabah currently resides in the Greater New York City Area.
Executive Team Culture Ratings from uniQure Employees
TOP
10%
uniQure's Executive Team scores in the Top 10%
of similar sized companies on Comparably
of similar sized companies on Comparably
Not Enough Ratings To Show Who Ranks Executive Team the Highest
Anonymously rate my experience at uniQureNot Enough Ratings To Show Who Ranks Executive Team the Lowest
Anonymously rate my experience at uniQureuniQure's Executive Team at a Glance
Based on 4 ratings, uniQure's employees are very satisfied with their Executive Team and give them an āAā or 81/100.
uniQure's Executive Team ranks in the Top 10% of other companies on Comparably that also have 201-500 Employees.
×